The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
p73 is a human p53-related protein that can induce apoptosis
Abstract
The protein p53 is the most frequently mutated tumour suppressor to be identified so far in human cancers. The ability of p53 to inhibit cell growth is due, at least in part, to its ability to bind to specific DNA sequences and activate the transcription of target genes such as that encoding the cell-cycle inhibitor p21Waf1/Cip1 . A gene has recently been identified that is predicted to encode a protein with significant amino-acid sequence similarity to p53. In particular, each of the p53 amino-acid residues implicated in direct sequence-specific DNA binding is conserved in this protein. This gene, called p73, maps to the short arm of chromosome 1, and is found in a region that is frequently deleted in neuroblastomas. Here we show that p73 can, at least when overproduced, activate the transcription of p53-responsive genes and inhibit cell growth in a p53-like manner by inducing apoptosis (programmed cell death).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p73 is a member of the p53 family of tumor suppressors and has similar transactivation functions relating to the induction of pro-apoptotic genes in response to cellular stress (17, 18).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [17]
In the citing paper
“The p53 family member p73α has functions similar to p53 (17, 18, 42, 43), but is regulated differently by Mdm2.”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [17]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,302
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1×
“In particular, each of the p53 amino-acid residues implicated in direct sequence-specific DNA binding is conserved in this protei”
BackgroundSuppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,659
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression
Kern, S. E., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K. W., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Flagged first, then by citations
1 of the 25 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Kaghad, M. et al. Monoallelically expressed gene related to p53 at the neuroblastoma suppressor-1 locus. Cell (in the press).
- Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752 (1987). · DOI
Cited by
Sorted by citations
Items 401–500 of 943
Cyclin D1 protein expression and gene polymorphism in colorectal cancer
McKay, J., Douglas, J. J., Ross, V. G., Curran, S., Murray, G. I., Cassidy, J., & Initiative, O. B. O. T. A. C. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001001)88:1 · Cited by 121
Clinical studies of p53 in treatment and benefit of breast cancer patients.
Bergh, J. C. S. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060051 · Cited by 40
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescencein situ hybridization
Moch, H., Sauter, G., Gasser, T. C., Bubendorf, L., Richter, J., Presti, J. C., Waldman, F. M., & Mihatsch, M. J. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199804)184:4 · Cited by 64
Mutation analysis of the p73 gene in nonastrocytic brain tumours
Alonso, M. E., Bello, M. J., González‐Gómez, P., Lomas, J., Arjona, D., de Campos, J. M., Kusak, M. E., Sarasa, J. L., Isla, A., & REY, J. A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1855 · Cited by 40
Chen, X., Sturgis, E. M., Etzel, C. J., Wei, Q., & Li, G. (2008) · Cancer · doi:10.1002/cncr.23976 · Cited by 37
Srdić‐Rajić, T., Zec, M. M., Todorović, T. R., Anđelković, K., & Radulovic, S. S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.039 · Cited by 39
Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
Kritsch, D., Hoffmann, F. S., Steinbach, D., Jansen, L., Photini, S. M., Gajda, M. R., Mosig, A. S., Sonnemann, J., Peters, S., Melnikova, M., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30860 · Cited by 40
Gomes, S., Raimundo, L., Soares, J., Loureiro, J. B., Leão, M., Ramos, H., Monteiro, M. N., Lemos, A., Moreira, J., Pinto, M. M. M., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.014 · Cited by 39
Aggarwal, M., Saxena, R., Asif, N., Sinclair, E., Tan, J., Cruz, I. M., Berry, D. L., Kallakury, B., Pham, Q., Wang, T. T. Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1267-z · Cited by 40
Role of SHP-2 Tyrosine Phosphatase in the DNA Damage-induced Cell Death Response
Yuan, L., Yu, W., Yuan, Z.-M., Haudenschild, C. C., & Qu, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211327200 · Cited by 39
Prognostic Impact of ΔTAp73 Isoform Levels and Their Target Genes in Colon Cancer Patients
Soldevilla, B., Díaz, R., Silva, J., Campos‐Martín, Y., Muñoz, C., García‐Barberán, V., García, J. M., Peña, C., Herrera, M., Rodríguez, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2388 · Cited by 39
Tumor suppressor genes in breast cancer.
Oesterreich, S., & Fuqua, S. A. W. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060405 · Cited by 39
p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome
Quesnel, S., Verselis, S. J., Portwine, C., Garber, J. E., White, M. B., Feunteun, J., Malkin, D. M., & Li, F. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202783 · Cited by 39
Sintich, S. M., Steinberg, J., Kozlowski, J. M., Lee, C., Pruden, S. J., Sayeed, S., & Sensibar, J. A. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990501)39:2 · Cited by 66
Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress
Frenkel, J., Sherman, D., Fein, A., Schwartz, D., Almog, N., Kapon, A., Goldfinger, N., & Rotter, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202518 · Cited by 39
Zhou, B., Liang, G., Qin, H., Peng, X., Huang, J., Li, Q., Li, Q., Zhang, L., Chen, L., Ye, L., et al. (2014) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2014.951814 · Cited by 39
p73 as a Pharmaceutical Target for Cancer Therapy
Bisso, A., Collavin, L., & Sal, G. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795222667 · Cited by 41
Roth, J. C., Koch, P., Contente, A., & Dobbelstein, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203500 · Cited by 38
Clurman, B. E., & Groudine, M. T. (1997) · Nature · doi:10.1038/38116 · Cited by 38
TAp73β and DNp73β activate the expression of the pro-survival caspase-2 S
Toh, W. H., Logette, E., Corcos, L., & Sabapathy, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn414 · Cited by 37
Overexpression of phosphorylated‐ATF2 and STAT3 in cutaneous angiosarcoma and pyogenic granuloma
Chen, S., Takeuchi, S., Urabe, K., Hayashida, S., Makiko, K. I. D. O., Tomoeda, H., Uchi, H., Dainichi, T., Takahara, M., Shibata, S., et al. (2007) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00887.x · Cited by 38
Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice
Nemajerová, A., Petrenko, O., Trümper, L. H. P., Palacios, G. F., & Moll, U. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40331 · Cited by 37
Stiewe, T., Stanelle, J., Theseling, C. C., Pollmeier, B., Beitzinger, M., & Pützer, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300357200 · Cited by 37
Takada, N., Ozaki, T., Ichimiya, S., Todo, S., & Nakagawara, A. (1999) · PubMed · Cited by 37
Wilson, C., Henry, S. E., Smith, M. A., & Bowser, R. P. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00496.x · Cited by 37
Hishida, A., Matsuo, K., Tajima, K., Ogura, M., Kagami, Y., Taji, H., Morishima, Y., Emi, N., Naoe, T., & Hamajima, N. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001638878 · Cited by 37
Programmed cell death: a missing link is found
Jacobson, M. D. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01182-3 · Cited by 37
Ding, Y. (1999) · DNA Research · doi:10.1093/dnares/6.5.347 · Cited by 37
Gene therapy for thyroid cancer
Barzon, L., Pacenti, M., Boscaro, M., & Palù, G. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1225 · Cited by 37
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function
Vella, V., Zhu, J., Frasca, F., Li, C.-Y., Vigneri, P. G., Vigneri, R., & Wang, J. Y. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301962200 · Cited by 37
Imyanitov, E. N., Birrell, G. W., Filippovich, I. V., Sorokina, N., Arnold, J. M., Mould, M. A., Wright, K., Walsh, M. D., Mok, S. C., Lavin, M. F., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202863 · Cited by 37
Expression of the β4 integrin subunit induces monocytic differentiation of 32D/v-Abl cells
Morena, A. R., Riccioni, S., Marchetti, A., Polcini, A. T., Mercurio, A. M., Blandino, G., Sacchi, A., & Falcioni, R. (2002) · Blood · doi:10.1182/blood.v100.1.96 · Cited by 37
Kaul, S. C., Sugihara, T., Yoshida, A., Nomura, H., & Wadhwa, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203696 · Cited by 37
Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma
Mihara, M., Nimura, Y., Ichimiya, S., Sakiyama, S., Kajikawa, S., Adachi, W., Amano, J., & Nakagawara, A. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690027 · Cited by 37
Nozaki, M., Tada, M., Kashiwazaki, H., Hamou, M., Diserens, A., Shinohe, Y., Sawamura, Y., Iwasaki, Y., de Tribolet, N., & Hegi, M. E. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00400.x · Cited by 37
p53 directly regulates the glycosidase FUCA1 to promote chemotherapy-induced cell death
Baudot, A. D., Crighton, D., O'Prey, J., Somers, J., Sierra Gonzalez, P., & Ryan, K. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191714 · Cited by 31
Accardi, R., Scalise, M., Gheit, T., Hussain, I., Yue, J., Carreira, C., Collino, A., Indiveri, C., Gissmann, L., Sylla, B. S., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00964-10 · Cited by 36
Sayagués, J. M., Tabernero, M. D., Maíllo, A., Díaz, P., Rasillo, A., Bortoluci, A., Gómez-Moreta, J. A., Santos-Briz, A. J., Morales, F., & Órfão, A. (2002) · Cytometry · doi:10.1002/cyto.10075 · Cited by 36
p73 Isoforms Can Induce T-Cell Factor–Dependent Transcription in Gastrointestinal Cells
Tomkova, K., Belkhiri, A., El-Rifai, W. M., & Zaika, A. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2176 · Cited by 36
Differential Effect of ik3-1/Cables on p53- and p73-induced Cell Death
Tsuji, K., Mizumoto, K., Yamochi, T., Nishimoto, I., & Matsuoka, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108535200 · Cited by 36
Guan, M., & Chen, Y. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.026955 · Cited by 36
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia
Lucena-Araujo, A. R., Kim, H. T., Thomé, C. H., Jácomo, R. H., Melo, R. A. M., Bittencourt, R., Pasqüini, R., Pagnano, K. B. B., Gloria, A. B. F., Chauffaille, M. D. L., et al. (2015) · Blood · doi:10.1182/blood-2015-01-623330 · Cited by 34
Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women
Valladares, A., García-Hernández, N., Gómez, F. S., Curiel‐Quesada, E., Madrigal‐Bujaidar, E., Vergara, M. D., Martínez, M. S., & Arenas-Aranda, D. J. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.06.002 · Cited by 36
Thioredoxin‐Related Regulation of NO/NOS Activities
Shao, L., Tanaka, T. S., Gribi, R., & Yu, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04064.x · Cited by 36
ΔNp73 can modulate the expression of various genes in a p53-independent fashion
Kartasheva, N. N., Lenz-Bauer, C., Hartmann, O., Schäfer, H., Eilers, M., & Dobbelstein, M. (2003) · Oncogene · doi:10.1038/sj.onc.1207138 · Cited by 37
gi, R. K., & Volm, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3 · Cited by 99
Failure of viral oncoproteins to target the p53-homologue p51A
Roth, J. C., & Dobbelstein, M. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-12-3251 · Cited by 36
Irvine, A. D., & Mellerio, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch15 · Cited by 35
Zhang, Y., Yan, W., Jung, Y.-S., & Chen, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.358143 · Cited by 35
Markowska, A., Kasprzak, B., Jaszczyńska-Nowinka, K., Lubin, J., & Markowska, J. (2015) · Współczesna Onkologia · doi:10.5114/wo.2015.54386 · Cited by 35
Predicting clinical outcomes of cancer patients with a p53 deficiency gene signature
Schaafsma, E., Takacs, E. M., Kaur, S., Cheng, C., & Kurokawa, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-05243-6 · Cited by 34
Full-length p73α Represses Drug-induced Apoptosis in Small Cell Lung Carcinoma Cells
Nyman, U., Pluta, A., Engskog‐Vlachos, P., Perlmann, T., Zhivotovsky, B., & Joseph, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500394200 · Cited by 36
p73 Overexpression and Angiogenesis in Human Colorectal Carcinoma
Guan, M. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg045 · Cited by 35
Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B
Martín, Á. G., Trama, J. P., Crighton, D., Ryan, K. M., & Fearnhead, H. O. (2009) · Aging · doi:10.18632/aging.100026 · Cited by 35
Kang, S., Wang, D., Li, W.-S., Wang, N., Zhou, R., Sun, D.-L., Duan, Y., Li, S., Li, X., & Li, Y. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a130ab · Cited by 34
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line
Goldschneider, D., Blanc, É., Raguénez, G., Barrois, M., Legrand, A., Roux, G. L., Haddada, H., Bénard, J., & Douc‐Rasy, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00834 · Cited by 34
Progress in the Molecular Biology of Ewing Tumors
Kovar, H. (1998) · Sarcoma · doi:10.1080/13577149878109 · Cited by 35
Kaida, A., Ariumi, Y., Ueda, Y., Lin, J.-Y., Hijikata, M., Ikawa, S., & Shimotohno, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203387 · Cited by 35
Nakano, H., Kohara, M., & Shinohara, K. (2001) · Cell and Tissue Research · doi:10.1007/s004410100438 · Cited by 35
Regulatory feedback loop between TP73 and TRIM32
González-Cano, L., Hillje, A., Fuertes-Álvarez, S., Marqués, M. M., Blanch, A., Ian, R. W., Irwin, M. S., Schwamborn, J. C., & Marín, M. C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.224 · Cited by 34
Bunjobpol, W., Dulloo, I., Igarashi, K., Concin, N., Matsuo, K., & Sabapathy, K. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.41 · Cited by 34
Kawano, S. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1151 · Cited by 34
Cutaneous fibrosis induced by docetaxel
Cleveland, M. G., Ajaikumar, B. S., & Reganti, R. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5 · Cited by 48
p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53
Almog, N., Goldfinger, N., & Rotter, V. (2000) · Oncogene · doi:10.1038/sj.onc.1203673 · Cited by 34
p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas
Loiseau, H., Arsaut, J., & Demotes‐Mainard, J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00130-5 · Cited by 34
Regulation of p73 by Hck through kinase-dependent and independent mechanisms
Paliwal, P., Radha, V., & Swarup, G. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-45 · Cited by 34
The effect of radioiodine treatment on the diseased thyroid gland
Riley, A., McKenzie, G. A. G., Green, V., Schettino, G., England, R. J., & Greenman, J. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1665206 · Cited by 34
Multilevel regulation and molecular mechanism of poly (rC)‐binding protein 1 in cancer
Zhang, X., Di, C., Chen, Y., Wang, J., Su, R., Huang, G., Xu, C., Chen, X., Long, F., Yang, H., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000911r · Cited by 33
Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
Sasaki, Y., Mita, H., Toyota, M., Ishida, S., Morimoto, I., Yamashita, T., Tanaka, T., Imai, K., Nakamura, Y., & Tokino, T. (2003) · PubMed · Cited by 33
iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy
Bell, H. S., & Ryan, K. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0182 · Cited by 33
Chaudhary, N., & Maddika, S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00101-14 · Cited by 33
Oh, Y. K., Lee, H. J., Jeong, M.-H., Rhee, M., Mo, J., Song, E. H., Lim, J.-Y., Choi, K., Jo, I., Park, S. I., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0297 · Cited by 34
Mittal, R. D., George, G. P., Mishra, J., Mittal, T., & Kapoor, R. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.03.001 · Cited by 33
Judson, H. K., Roy, N. V., Strain, L., Vandesompele, J., Gele, M. V., Speleman, F., & Bonthron, D. T. (2000) · Human Genetics · doi:10.1007/s004390000257 · Cited by 33
p19 Interacts with and Activates p73 by Involving the MDM2 Protein
Jeong, M.-H., Bae, J., Kim, W., Yoo, S.-M., Kim, J.-W., Song, P. I., & Choi, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513853200 · Cited by 33
Molecular Genetics in the Diagnosis and Prognosis of Solid Pediatric Tumors
Thorner, P. S., & Squire, J. A. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900049 · Cited by 31
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer
Jung, O., Baek, M.-J., Wooldrik, C., Johnson, K. R., Fisher, K. W., Lou, J., Ricks, T. J., Wen, T., Best, M. D., Cryns, V. L., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00085-6 · Cited by 34
Taebunpakul, P., Sayan, B. S., Flinterman, M., Klanrit, P., Gäken, J. A., Odell, E. W., Melino, G., & Tavassoli, M. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0720-7 · Cited by 31
Leung, T. H.-Y., & Ngan, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0688 · Cited by 34
Lotan, T. L., Hickson, J. A., Souris, J. S., Huo, D., Taylor, J., Li, T., Otto, K. B., Yamada, S. D., Macleod, K. F., & Rinker-Schaeffer, C. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1568 · Cited by 32
Characterization of p73 functional domains necessary for transactivation and growth suppression
Nozell, S. E., Wu, Y., McNaughton, K., Liu, G., Willis, A. C., Paik, J. C., & Chen, X. (2003) · Oncogene · doi:10.1038/sj.onc.1206470 · Cited by 32
Analysis of p73 and p53 gene deletions in multiple myeloma
Schultheis, B. S., Krämer, A., Willer, A., Hegenbart, U., Goldschmidt, H., & Hehlmann, R. (1999) · Leukemia · doi:10.1038/sj.leu.2401609 · Cited by 32
Yk, C., Ss, H., & Lin, L. (2003) · Oral Diseases · doi:10.1034/j.1601-0825.2003.02920.x · Cited by 32
Proteomics Identification of Azaspiracid Toxin Biomarkers in Blue Mussels, Mytilus edulis
Nzoughet, J. K., Hamilton, J. T. G., Botting, C. H., Douglas, A., Devine, L., Nelson, J., & Elliott, C. T. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800561-mcp200 · Cited by 31
p73: From the p53 shadow to a major pharmacological target in anticancer therapy
Ramos, H., Raimundo, L., & Saraiva, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105245 · Cited by 33
Deacetylation of Transcription Factors in Carcinogenesis
Hałasa, M., Adamczuk, K., Adamczuk, G., Afshan, S., Stepulak, A., Cybulski, M., & Wawruszak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111810 · Cited by 32
Li, Y., Wu, X., Li, J., Du, L., Wang, X., Cao, J., Li, H., Huo, Z., Li, G., Pan, D., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2776440 · Cited by 31
Yuan, L., Yu, W., Xu, M., & Qu, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506768200 · Cited by 31
p53 Family Members Regulate the Expression of the Apolipoprotein D Gene
Sasaki, Y., Negishi, H., Koyama, R., Anbo, N., Ohori, K., Idogawa, M., Mita, H., Toyota, M., Imai, K., Shinomura, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807185200 · Cited by 31
Wang, Y., Radhakrishnan, D., He, X., Peehl, D. M., & Eng, C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3490 · Cited by 31
Transcriptional Inhibition of p53 by the MLL/MEN Chimeric Protein Found in Myeloid Leukemia
Maki, K., Mitani, K., Yamagata, T., Kurokawa, M., Kanda, Y., Yazaki, Y., & Hirai, H. (1999) · Blood · doi:10.1182/blood.v93.10.3216.410k45_3216_3224 · Cited by 31
Specific and conserved roles of TAp73 during zebrafish development
Rentzsch, F., Kramer, C., & Hammerschmidt, M. (2003) · Gene · doi:10.1016/j.gene.2003.10.002 · Cited by 31
Loss of heterozygosity on hromosome 1 in sporadic colorectal carcinoma
Zhou, C. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i10.1431 · Cited by 31
Herranz, M., Santos, J., SALIDO, E. C., Fernández‐Piqueras, J., & Serrano, M. (1999) · PubMed · Cited by 31
Structure of the C-terminal sterile α-motif (SAM) domain of human p73α
Wang, W. K., Bycroft, M., Foster, N. W., Buckle, A. M., Fersht, A. R., & Chen, Y. W. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901002529 · Cited by 31
Brooks, L., Sullivan, A., O’Nions, J., Bell, A., Dunne, B., TIDY, J. A., Evans, D. J., Osin, P., Vousden, K. H., Gusterson, B. A., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600033 · Cited by 31
Transcriptional activities of p73 splicing variants are regulated by inter-variant association
Ueda, Y., Hijikata, M., Takagi, S., Chiba, T., & Shimotohno, K. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560859 · Cited by 31
Hernandez-Acosta, N. C., Cabrera‐Socorro, A., Morlans, M. P., Delgado, F. J. G., Suárez-Solá, M. L., Sottocornola, R., Lü, X., González‐Gómez, M., & Meyer, G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.041 · Cited by 30
Germline mutations in the p73 gene do not predispose to familial prostate‐brain cancer
Peters, M. A., Janer, M., Kolb, S., Jarvik, G. P., Ostrander, E. A., & Stanford, J. L. (2001) · The Prostate · doi:10.1002/pros.1109 · Cited by 30
Yeo, C. I., Ooi, K. K., Akim, A. M., Ang, K. P., Fairuz, Z. A., Halim, S. N. A., Ng, S. W., Seng, H., & Tiekink, E. R. T. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.05.011 · Cited by 30
Metadata
- Authors
- Jost, C. A., Marin, M. C., & Jr, W. G. K.
- Affiliations
- Harvard University (US)
- Venue
- Nature
- Published
- 1997-09-11
- Volume
- 389
- Issue
- 6647
- Pages
- 191-194
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1675096266
- Cited by
- 948
- References
- 25
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 13 · 2023: 7 · 2022: 15 · 2021: 18 · 2020: 13 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 18 · 2015: 20 · 2014: 19 · 2013: 25 · 2012: 26
- FWCI
- 34.25
- Type
- journal article
- Language
- en
- Update notices
- erratum (1999-06-24)
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p73, p53, tumor suppressor proteins, apoptosis, transcriptional activation, cell growth inhibition, neuroblastoma, chromosome 1p deletion, p21, programmed cell death
- MeSH terms
- Tumor Protein p73, Cell Division, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 1, DNA-Binding Proteins, Growth Inhibitors, Humans, Molecular Sequence Data, Neuroblastoma, Nuclear Proteins, Plasmids, Tumor Cells, Cultured, Chloramphenicol O-Acetyltransferase, Transcriptional Activation, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, Cyclins, Mutagenesis, Site-Directed, Apoptosis, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review